Related references
Note: Only part of the references are listed.Progress Toward a Staphylococcus aureus Vaccine
Robert S. Daum et al.
CLINICAL INFECTIOUS DISEASES (2012)
Development of a vaccine against Staphylococcus aureus
Brad Spellberg et al.
SEMINARS IN IMMUNOPATHOLOGY (2012)
Strategies for and advances in the development of Staphylococcus aureus prophylactic vaccines
Jane Broughan et al.
EXPERT REVIEW OF VACCINES (2011)
Methicillin-Resistant Staphylococcus aureus Infection and Hospitalization in High-Risk Patients in the Year following Detection
Susan S. Huang et al.
PLOS ONE (2011)
Searching for the Holy Grail of a staphylococcal vaccine
Isaac Thomsen et al.
HUMAN VACCINES (2010)
Synthetic β-(1→6)-Linked N-Acetylated and Nonacetylated Oligoglucosamines Used To Produce Conjugate Vaccines for Bacterial Pathogens
Marina L. Gening et al.
INFECTION AND IMMUNITY (2010)
Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice
David Skurnik et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The potential economic value of a Staphylococcus aureus vaccine for neonates
Bruce Y. Lee et al.
VACCINE (2010)
Staphylococcus aureus vaccine for orthopedic patients: An economic model and analysis
Bruce Y. Lee et al.
VACCINE (2010)
Comparative impact assessment of child pneumonia interventions
Louis Niessen et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2009)
Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease
Dan M. Granoff
VACCINE (2009)
The impact of antimicrobial-resistant, health care-associated infections on mortality in the United States
R. Monina Klevens et al.
CLINICAL INFECTIOUS DISEASES (2008)
Strain-relatedness of methicillin-resistant Staphylococcus aureus isolates recovered from patients with repeated infection
Susan S. Huang et al.
CLINICAL INFECTIOUS DISEASES (2008)
Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae
Caroline L. Trotter et al.
VACCINE (2008)
Invasive methicillin-resistant Staphylococcus aureus infections in the United States
R. Monina Klevens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide
Nuno Cerca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care
Linda F. McCaig et al.
EMERGING INFECTIOUS DISEASES (2006)
Methicillin-resistant S-aureus infections among patients in the emergency department
Gregory J. Moran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated staphylococcal poly-N-acetyl-β-(1-6)-glucosamine
T Maira-Litrán et al.
INFECTION AND IMMUNITY (2005)
Advances in pneumococcal vaccines - Advantages for infants and children
J Bernatoniene et al.
DRUGS (2005)
Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization
SS Huang et al.
CLINICAL INFECTIOUS DISEASES (2003)
Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.
H Shinefield et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children
FYC Lin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
